Antibodies from original Covid virus strain don’t bind to variants: Study
PTI, Sep 21, 2021, 3:26 PM IST
Credit: iStock Photo
Washington: People infected with the original strain of the virus that causes COVID-19 early in the pandemic produced antibodies that don’t bind well to newer variants, according to a study.
The finding, published in the journal Nature Communications, has implications for the ability of new variants to reinfect people who contracted earlier versions of the virus, as well as for the continuing efficacy of vaccines and the design of booster shots.
The researchers mined published papers about COVID-19 patients for data about the sequence of the antibodies they produced.
They focused on antibodies against the spike protein, the part of the virus that binds to receptors on human cells to infect them.
The spike protein is the target of most vaccines.
The team found that many antibody sequences converged into two main groups, indicating a consistent human immune response to the virus.
“We really focused on characterising the antibodies created in those infected with the original strain of the virus,” said study first author Timothy Tan, a graduate student at the University of Illinois Urbana-Champaign, US.
“Before we started the study, variants weren’t much of a problem. As they emerged, we wanted to see whether the common antibodies we identified were able to bind to newer variants,” Tan said.
The researchers studied the convergent antibodies’ ability to bind to several variants and found that they no longer bound to some.
When people make quite similar antibodies to a particular virus, it is called convergent antibody response.
“Even though this antibody response is very common with the original strain, it doesn’t really interact with variants,” said study leader Nicholas Wu, a professor at the University of Illinois.
This raises the concern of the virus evolving to escape the body’s main antibody response, the researchers said.
Some antibodies should still be effective — the body makes antibodies to many parts of the virus, not only the spike protein — but the particular groups of antibodies seen in the study will not be as effective, they said.
The researchers said they would like to conduct similar studies characterising antibody response for Delta and other variants, to see whether they also produce a convergent response and how it differs from the original strain.
“We want to design vaccines and boosters, if needed, that can protect a majority of the population,” Tan said.
“We expect that the antibody response to those variants would be quite different,” he added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
Low back pain, depression, headaches main causes of poor health: Study
MUST WATCH
Latest Additions
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post
Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm
‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi